The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Twenty-one-gene recurrence score (RS) in germline (g)CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study.
 
Anosheh Afghahi
No Relationships to Disclose
 
Sydney Marsh
No Relationships to Disclose
 
Alyse Winchester
No Relationships to Disclose
 
Dexiang Gao
No Relationships to Disclose
 
Hannah Parris
No Relationships to Disclose
 
Lisen Axell
No Relationships to Disclose
 
Leif W. Ellisen
No Relationships to Disclose
 
Erin Wysong Hofstatter
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - Arvinas (I)
Consulting or Advisory Role - Teladoc
Patents, Royalties, Other Intellectual Property - UpToDate contributor royalties
Other Relationship - UpToDate
 
Allison W. Kurian
Research Funding - Myriad Genetics (Inst)
Other Relationship - Ambry Genetics; Color Genomics; GeneDx/BioReference; Genentech; InVitae
 
Marie Wood
Consulting or Advisory Role - AstraZeneca (Inst); HERON (Inst)
 
Dana Zakalik
No Relationships to Disclose
 
Carol-Ann Mullin
No Relationships to Disclose
 
Jennifer Lee Caswell-Jin
Research Funding - QED Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Color Genomics; Natera
 
Virginia F. Borges
Consulting or Advisory Role - Seagen
Research Funding - AstraZeneca (Inst); Olema Oncology (Inst); oncosec (Inst); Seagen (Inst)
 
Nadine M. Tung
Research Funding - AstraZeneca (Inst)